Health Outcomes from Multidrug-Resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis.
暂无分享,去创建一个
Martyn D Kirk | Samantha Vilkins | Kathryn Glass | Andrea Parisi | Luis Furuya-Kanamori | J. Crump | M. Kirk | L. Furuya-Kanamori | K. Glass | A. Parisi | John A Crump | B. Howden | Benjamin P Howden | D. Gray | Darren J Gray | Samantha Vilkins
[1] T. Barrett,et al. Hospitalization and Antimicrobial Resistance in Salmonella Outbreaks, 1984–2002 , 2005, Emerging infectious diseases.
[2] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[3] D. Vugia,et al. Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006-2008. , 2014, Foodborne pathogens and disease.
[4] T. Jones,et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. , 2005, The Journal of infectious diseases.
[5] D. Middleton,et al. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. , 2004, The Journal of infectious diseases.
[6] L. Ng,et al. Ceftiofur Resistance in Salmonella enterica Serovar Heidelberg from Chicken Meat and Humans, Canada , 2010, Emerging infectious diseases.
[7] N. Beeching,et al. A retrospective study of secondary bacteraemia in hospitalised adults with community acquired non-typhoidal Salmonella gastroenteritis , 2013, BMC Infectious Diseases.
[8] R. Hoekstra,et al. Antimicrobial Resistance Among Nontyphoidal Salmonella Isolated From Blood in the United States, 2003-2013. , 2015, The Journal of infectious diseases.
[9] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[10] Peter Gerner-Smidt,et al. Excess Mortality Associated with Antimicrobial Drug-Resistant Salmonella Typhimurium , 2002, Emerging infectious diseases.
[11] T. Barrett,et al. Emergence of Multidrug-Resistant Salmonella enterica Serotype Newport Infections Resistant to Expanded-Spectrum Cephalosporins in the United States , 2003 .
[12] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[13] D. Walker,et al. Higher hospital costs and lengths of stay associated with quinolone-resistant Salmonella enterica infections in Hong Kong. , 2010, Journal of public health.
[14] M. Barza. Potential mechanisms of increased disease in humans from antimicrobial resistance in food animals. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] C. Chiu,et al. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] M. Gordon. Salmonella infections in immunocompromised adults. , 2008, The Journal of infection.
[17] A. Cronquist,et al. Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002-2003. , 2005, Microbial drug resistance.
[18] Mike Clarke,et al. Is Evidence-Based Medicine Relevant to the Developing World? , 2005, Evidence-based complementary and alternative medicine : eCAM.
[19] Gail M. Williams,et al. Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. , 2015, Contemporary clinical trials.
[20] R. Barlow. Emerging nontyphoidal salmonella antibiotic resistance in Oregon 2004-2009 : risk factors and trends , 2012 .
[21] M. Falagas,et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[22] K. Mølbak,et al. The interaction between prior antimicrobial drug exposure and resistance in human Salmonella infections. , 2010, The Journal of antimicrobial chemotherapy.
[23] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[24] S. Zansky,et al. Multidrug-resistant nontyphoidal Salmonella in New York state's foodborne diseases active surveillance network counties. , 2010, Foodborne pathogens and disease.
[25] E. K. Maloney,et al. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. , 1994, The Journal of infectious diseases.
[26] J. Barendregt,et al. A new improved graphical and quantitative method for detecting bias in meta-analysis. , 2018, International journal of evidence-based healthcare.
[27] J. Kwong,et al. Emergence of multidrug resistance in locally-acquired human infections with Salmonella Typhimurium in Australia owing to a new clade harbouring blaCTX-M-9. , 2017, International journal of antimicrobial agents.
[28] P. Fey,et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. , 2000, The New England journal of medicine.
[29] L. Majtánová,et al. Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009. , 2010, Diagnostic microbiology and infectious disease.
[30] S. Chu,et al. Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Gail M. Williams,et al. Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model. , 2015, Contemporary clinical trials.
[32] K. Mølbak,et al. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. , 2004, The Journal of infectious diseases.
[33] S. Holmberg,et al. Drug-resistant Salmonella from animals fed antimicrobials. , 1984, The New England journal of medicine.
[34] J. Crump,et al. Antimicrobial Resistance among Invasive Nontyphoidal Salmonella enterica Isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007 , 2011, Antimicrobial Agents and Chemotherapy.
[35] P. Hsueh,et al. Bacteraemia due to ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis in adult patients at a university hospital in Taiwan, 1996–2004 , 2006, Epidemiology and Infection.
[36] Tine Hald,et al. World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis , 2015, PLoS medicine.
[37] M. Tobin-D'Angelo,et al. Salmonellosis outcomes differ substantially by serotype. , 2008, The Journal of infectious diseases.